Production Of Nanoparticles Research Articles

Eco-friendly synthesis and surface modification of ZnO nanoparticles using Pueraria montana root extract: enhanced photocatalytic performance with trisodium pyrophosphate

ABSTRACT The synthesis of zinc oxide (ZnO) nanoparticles using Pueraria montana (kudzu) plant extracts highlights advancements in green nanotechnology. This study explores the use of Pueraria montana roots, rich in phytochemicals such as phenols, terpenoids and flavonoids, which serve as natural reducing and stabilizing agents for nanoparticle synthesis. The eco-friendly production and surface modification of ZnO nanoparticles were achieved using these plant extracts, enhancing their photocatalytic performance with trisodium pyrophosphate (TSPP).Characterization techniques, including XRD, TEM, and FE-SEM, confirmed the nanoparticles’ crystalline structure, with a BET surface area of 14.01 m²/g and a type II adsorption isotherm. The synthesized nanoparticles exhibited exceptional dye degradation capabilities, achieving 99.9% removal of malachite green (MG) and 97.78% for aniline blue (AB). Kinetic analysis revealed a steady-state rate constant (k) of 2 × 10⁻⁴ min⁻¹ for MG where as the response rate constant(k) for the photocatalytic degradation of AB using modified ZnO nanostructures was 3.0 × 10−3 min−1 allowing near-total dye removal within 600 minutes for MG and 350 min for AB . Adsorption studies were well described by Langmuir and Freundlich isotherms, indicating maximum adsorption capacities of 59.7 mg/g for MG and 61.2 mg/g for AB. Surface modification with TSPP improved charge carrier separation and enhanced the generation of reactive oxygen species under UV exposure, further increasing dye degradation efficiency.Statistical analysis indicated high reproducibility, with close mean adsorption values of 99.125 for MG and 97.3125 for AB, supported by small standard deviations. The findings affirm the potential of using Pueraria montana in synthesizing efficient photocatalysts, providing a sustainable and cost-effective approach for water treatment applications. Overall, this research underscores the effectiveness of plant-based materials in advancing eco-friendly nanotechnology solutions.

Modeling the Production Process of Lignin Nanoparticles Through Anti-Solvent Precipitation for Properties Prediction

Global warming has recently intensified research interest in renewable polymer chemistry, with significant attention directed towards lignin nanoparticle (LNP) synthesis. Despite progress, LNP industrial application faces challenges: (1) reliance on kraft lignin from declining raw biomass processes, (2) sulfur-rich and condensed lignin use, (3) complex lignin macroparticles to LNP conversion, using harmful and toxic solvents, and, above all, (4) lack of control over the LNP production process (i.e., anti-solvent precipitation parameters), resulting in excessive variability in properties. In this work, eco-friendly LNPs with tailored properties were produced from a semi-industrial organosolv process by studying anti-solvent precipitation variables. Using first a parametric and then a Fractional Factorial Design, predictions of LNP sizes and size distribution, as well as zeta-potential, were derived from a model over beech by-products organosolv lignin, depending on initial lignin concentration (x1, g/L), solvent flow rate (x2, mL/min), antisolvent composition (x3, H2O/EtOH v/v), antisolvent ratio (x4, solvent/antisolvent v/v), and antisolvent stirring speed (x5, rpm). This novel chemical engineering approach holds promise for overcoming the challenges inherent in industrial lignin nanoparticle production, thereby accelerating the valorization of lignin biopolymers for high value-added applications such as cosmetics (sunscreen or emulsion) and medicine (encapsulation, nanocarriers), a process currently constrained by significant limitations.

Green chemistry approach to synthesize titanium dioxide nanoparticles using Fagonia Cretica extract, novel strategy for developing antimicrobial and antidiabetic therapies

Abstract This groundbreaking study explores the eco-friendly production of titanium dioxide nanoparticles (TiO2 NPs) to investigate their impact on health. TiO2 NPs were synthesized utilizing a plant extract from Fagonia cretica, acting as both stabilizers and reducers. Various techniques, including energy dispersive X-ray (EDX), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), UV-Vis, and X-ray diffraction (XRD), were employed to analyze the synthesized TiO2 NPs. FT-IR revealed functional groups crucial for nanoparticle (NP) formation. SEM confirmed the particle size of synthesized TiO2 NPs, ranging from 20 to 80 nm. XRD analysis highlighted the rutile phase crystalline structure, and EDX determined the elemental composition of TiO2 NPs. These NPs displayed potent antimicrobial properties, proving toxic to bacterial and the fungal strains at 50 µg·mL−1 concentration. Impressively, TiO2 NPs showcased significant antidiabetic effects in adult male albino mice, effectively reducing Streptozotocin-induced hyperglycemia and hypercholesterolemia by the improvement in behavior via random blood glucose, triglyceride, low density lipoproteins, high density lipoprteins, very low density lipoproteins, and GTT pathway at 100 and 200 µL. Furthermore, they exhibited a remarkable impact on human liver cancer cell lines, with a 43.2% reduction in cell viability at 100 µg·mL−1 concentration. In essence, the study highlights TiO2 NPs as a safe, natural therapeutic agent with immense potential in diabetes treatment. The MTT assay was utilized to assess their cytotoxicity and biocompatibility, affirming their promising role in healthcare.

Antibacterial and Photocatalytic Applications of Silver Nanoparticles Synthesized from Lacticaseibacillus rhamnosus

The biosynthesis of silver nanoparticles (AgNPs) presents an innovative and sustainable approach in nanotechnology with promising applications in fields such as medicine, food safety, and pharmacology. In this study, AgNPs were successfully synthesized using the probiotic strain Lacticaseibacillus rhamnosus (BCRC16000), addressing challenges related to stability, biocompatibility, and scalability that are common in conventional nanoparticle production methods. The formation of AgNPs was indicated by a color change from yellow to brown, and UV–visible spectrophotometry confirmed their presence with a characteristic absorption peak at 443 nm. Furthermore, Fourier transform infrared (FTIR) spectroscopy revealed the involvement of biomolecules in reducing silver ions, which suggests their role in stabilizing the nanoparticles. In addition, field emission scanning electron microscopy (FE-SEM) showed significant morphological and structural changes. At the same time, dynamic light scattering (DLS) and zeta potential analyses provided valuable insights such as average size (199.7 nm), distribution, and stability, reporting a polydispersity index of 0.239 and a surface charge of −36.3 mV. Notably, the AgNPs demonstrated strong antibacterial activity and photocatalytic efficiency, underscoring their potential for environmental and biomedical applications. Therefore, this study highlights the effectiveness of Lacticaseibacillus rhamnosus in the biosynthesis of AgNPs, offering valuable antibacterial and photocatalytic properties with significant industrial and scientific implications.

Preparation and characterization of micellar nanoparticles using crude saponins from five Congolese plant species

Nanoparticles (NPs) have significantly advanced medical applications, including drug delivery, immunotherapy, vaccines, and diagnostics. This versatility is partly due to the potential of tailoring NPs from multiple sources. Notably, saponins, amphiphilic plant metabolites, have shown great promise in NP formulation. This study explored the development of micellar NPs using saponin crude fractions (SCFs) extracted from five Congolese plant species: Millettia laurentii, Penthaclethra eetveldeana, Schwenckia americana, Musa paradisiaca, and Musa sapientum. Plant materials were subjected to histological examination through optical microscopy, while phytochemical analyses by thin-layer chromatography confirmed the presence and predominance of saponins in the SCFs. We used a phthalocyanine-isoniazid hybrid (Pc-INH) as a hydrophobic probe to determine the critical micellar concentrations of SCFs and explore the feasibility of developing cost-effective saponin-based micelles (SBMs). Phytochemical screenings indicated saponins in the extracted SCF and other metabolites like flavonoids, phenolic acids, and anthocyanins. Dynamic light scattering and transmission electron microscopy analyses revealed the formation of nano-sized particles, particularly noting SBMs from P. eetveldeana with notable dimensions (157 nm, PDI of 0.27, and ZP of -4.01 mV) and spherical shape. The micelles from M. laurentii exhibited superior encapsulation efficiency for Pc-INH (55%) compared to control micelles formulated from pure saponin (33%). In vitro tests showed that M. paradisiaca SBMs have the best safety profile for red blood cells, with a 10% hemolysis rate compared to a 150% rate for bulk SCFs. However, there is a significant difference between SCFs and SBMs (p < 0.0001). The release profiles of M. paradisiaca SBMs show a pH-dependent relationship, suggesting potential for stimuli-responsive drug delivery. This work lays the foundation for leveraging plant-derived crude saponins in nanotechnology, emphazising their encapsulation efficiency, controlled release potential, and biocompatibility, paving the way for the cost-effective production of high-value biomedical NPs.

Optimising the production of PLGA nanoparticles by combining design of experiment and machine learning.

Poly(lactic-co-glycolic acid) (PLGA) is a widely used biodegradable polymer in drug delivery and nanoparticle (NP) formulation due to its controlled drug release properties and safety profiles. Among the methods available for NP production, nanoprecipitation is distinguished by its simplicity and scalability. However, it requires careful optimisation to achieve the desired NP characteristics, making the process potentially lengthy and costly. This study aimed to assess and compare the predictive performance of Design of Experiments (DOE) and Machine Learning (ML) models for the optimisation of PLGA nanoparticle size and zeta potential produced by nanoprecipitation. Various ML methods were employed to predict particle size, with Extreme Gradient Boosting (XGBoost) identified as the best performing. The key finding is that integrating ML with DOE provides deeper insights into the dataset than either method alone. While ML outperformed DOE in predictive performance, as evidenced by lower root mean squared error values and higher coefficients of determination, both methods struggled to accurately predict zeta potential, generating models with high errors. However, ML proved more effective in identifying the parameters that most significantly influence NP size, even with a smaller DOE dataset. Combining DOE datasets with ML for parameter importance was particularly advantageous in situations where data is limited, offering superior predictive power and the potential to streamline experimental design and optimisation. These results suggest that the synergistic use of ML and DOE can lead to more robust feature analysis and improved optimisation outcomes, particularly for NP size. This integrated approach can enhance the accuracy of predictions and supports more efficient experimental design, streamlining nanoparticle production processes, especially under resource-constrained conditions.

Biogenically synthesized gold nanocarrier ameliorated antiproliferative and apoptotic efficacy of doxorubicin against lung cancer

IntroductionConventional chemotherapy treatment is commonly linked to significant side effects due to high therapeutic doses. In this regard, nanoformulations with chemotherapeutic medications hold promise in enhancing drug effectiveness through the reduction of therapeutic dosages, thereby mitigating the potential for adverse side effects. Because of numerous applications in the biomedical arena, there has been a rising interest in developing an environmentally acceptable, long-lasting, and affordable technique for the production of gold nanoparticles. In this particular context, the incorporation of plant extracts in the production of metallic nanoparticles has garnered the interest of numerous scholars. Here, we report the synthesis of gold particles by the green method using Cannabis sativa L. leaf extract and their conjugation with doxorubicin.MethodsThe gold nanoparticles were synthesized by using Cannabis sativa extract and were characterized with various biophysical techniques. Subsequently, gold nanoparticles were conjugated with doxorubicin and their efficacy was tested on A549 cells.Results and DiscussionThe biogenic synthesis of gold nanoparticles was ascertained through an absorption peak at a wavelength of 524 nm, and it was shifted to 527 nm when conjugated with doxorubicin. Nanoparticles were found to be stable exhibiting a zeta potential value of −20.1 mV, and it changed to −12.7 mV when loaded with doxorubicin. The hydrodynamic diameter of nanoparticles was determined to be 45.64 nm and it was increased to 58.95 nm when conjugated with the drug. The average size of nanoparticles analyzed by TEM was found to be approximately 17.2 nm, while it was 23.5 nm in the case of drug-nanoconjugate. Moreover, there was a significant amelioration in the antiproliferative potential of doxorubicin against lung cancer A549 cells when delivered with gold nanocarrier, which was evident by the lower IC50 and IC75 values of drug-nanoconjugates in comparison to drug alone. Furthermore, the inhibitory effect of drug-nanoconjugates and drug alone was characterized by alteration in the cell morphology, nuclear condensation, increased production of reactive oxygen species, abrogation of mitochondrial membrane potential, and enhanced caspase activities in A549 cells. In sum, our results suggested enhanced efficacy of doxorubicin-gold nanoconjugates, indicating effective delivery of doxorubicin inside the cell by gold nanoparticles.

Alpha-Pinene-encapsulated lipid nanoparticles diminished inflammatory responses in THP-1 cells and imiquimod-induced psoriasis-like skin injury and splenomegaly in mice

IntroductionPsoriasis, a persistent skin condition caused by the disorder of the immune system, impacts approximately 1.25 million individuals globally. Nevertheless, the presence of adverse effects in conventional clinical drugs necessitates further exploration of novel medications or combination therapies to mitigate these reactions and enhance their effectiveness.MethodsHence, our intention here in this paper is to utilize the lipid nanoparticle delivery system for overcoming the volatility and hydrophobic properties of α-pinene, a naturally occurring compound renowned for its anti-inflammatory and antiviral effects, and further explore its potential pharmacological applications both in vitro and in vivo.ResultsThe production of α-pinene lipid nanoparticles (APLNs) was achieved through the utilization of high pressure homogenization methods. APLNs was successfully fabricated with enhanced stability and water solubility. Meanwhile, the application of APLNs could drastically reduce the expression of lipopolysaccharide (LPS)-induced inflammation-related factors in THP-1 cells. Administration of APLNs to a mouse model of auricular swelling could effectively reduce redness and swelling in the auricles of mice as well. Furthermore, APLNs were also found to alleviate skin damage in mice with Imiquimod (IMQ)-induced psoriasis model, as well as decrease the levels of psoriasis-related protein nuclear factor kappa-B (NF-κB) and interleukin-17 (IL-17), interleukin-23 (IL-23), and other inflammation-related cytokines. More importantly, utilization of APLNs successfully mitigated the systemic inflammatory reactions in mice, resulting in the reduction of spleen-to-body ratio (wt%) and of inflammatory cytokines’ expression in the serum.DiscussionOverall, our results suggest that with the help of lipid nanoparticle encapsulation, APLNs possess a better pharmacological effect in anti-inflammation and could potentially serve as an anti-psoriasis drug.

Effect of Environmental Factors on The Production of Silver Nanoparticles by Yeast Strains

In the presented work, the literature data on the influence of various environmental factors were analyzed on the formation of silver nanoparticles by yeast strains. It was determined that the optimal conditions for the synthesis of silver nanoparticles by the yeast strain Saccharomyces ellipsoideus BSU-XR1 were on the 21st day of incubation, on 4-6 days of incubation in different strains of Saccharomyces cerevisiae, and between 2-10 days in Candida strains. The optimal amount of wet biomass was between 8 and 10 g for Candida strains and 10 g for Saccharomyces strains. The temperature limit for Saccharomyces was observed at 25-35°C, and for Candida at 25-37°C. For strains, synthesis of silver nanoparticles was optimal in the pH range of 4-10, and pH range of 7 for Candida strains. Depending on the concentration of AgN03 salt, the optimal synthesis of silver nanoparticles occurred at concentrations of 0.5 and 1 mM for Saccharomyces, and 1 mM for Candida. The optimal incubation conditions for both sexes were under dark environment.

Nanoparticles: balancing benefits, ecological risks, and remediation approaches

Nanoparticles are the simplest form of structure, having sizes ranging from 1 to 100 nm and can provide considerably high surface areas through rational design. Their size, shape and structure are responsible for their high reactivity and strength. In the last few decades, nanoparticles have been widely used in many dosage forms due to their excellent solubility, less size and better penetrability. They have attained prominence in various technological advancements because their properties can be tuned as desired via precisely controlling the size, shape, synthesis conditions, and appropriate functionalization. Due to these unique properties, Nanoparticles have acquired a substantial global market in various commercial and domestic applications, including catalysis, imaging, medical applications, sports equipment, sensors, energy-based research, and environmental applications. Due to the increased growth of the production of nanoparticles and their industrial applications, issues relating to toxicity are inevitable. Several reports are available on the benefits of these nanomaterials in various sectors, but relatively more minor literature is available on their effect on the environment and human health. Several heavy metal nanoparticles are reported to be so rigid and stable that their degradation is not readily achievable, leading to much environmental toxicity. This review discusses a brief history, various applications and the possible fate of the Nanoparticles after use. In particular, we describe how Nanoparticles affect the environment, natural resources, natural micro-flora and humankind. It also describes several techniques currently being used to remove nanoparticles.

Synthesis of gold nanoparticles using soybean byproducts: applications in catalysis

AbstractThis study demonstrates the feasibility of extracting lecithin from oil industry byproducts in an eco‐friendly manner, with minimal use of water and without harmful chemicals. Liposomes can be generated directly from this extracted lecithin, enhancing the value of these byproducts and enabling the production of catalytic gold nanoparticles (AuNPs). Thin‐layer chromatography of the extracted lecithin revealed a phospholipid composition primarily consisting of phosphatidylethanolamine and phosphatidylcholine, and surface tension studies demonstrated similar behavior between the extracted and commercial lecithin. Liposome formation using sustainable lecithin (LPn) resulted in structures that were stable for at least 10 days, exhibiting a low polydispersity index (0.395) and uniform size (approximately 214 ± 7 nm). Gold nanoparticles were synthesized successfully in LPn loaded with [HAuCl4] by using different photoreduction methods: ultraviolet (UV) lamp, pulsed laser 355 nm, and sunlight irradiation. The AuNPs exhibited characteristic sizes (ranging from 5.03 to 6.78 nm) and optical properties typical of nanoparticles, including a distinct surface plasmon resonance. As a proof of concept, we also demonstrated that the synthesized AuNPs exhibited catalytic activity in UV‐induced cis‐trans isomerization reactions. Overall, the study highlights the potential of sustainable soy lecithin extraction for diverse applications, including nanoparticle synthesis and catalysis.

Synthesis of Zinc Sulfide Luminescent Nanoparticles Using Zinc Metal Complexes of S-benzyl Dithiocarbonate via Microwave Irradiation Route

This paper reported highly luminous zinc sulfide (ZnS) nanoparticles grown by microwave-irradiated single molecular precursors. The precursor was obtained by Schiff bases of S-benzyl dithiocarbazate (SBDTC) ligand using 5-Bromo-4-hydroxy-3-methoxy-2-nitro Benzaldehyde; 4NNbiscyno diethylamino benzaldehyde and p-amino acetophenone. The nanoparticles obtained were characterized by X-ray diffraction studies for structural analysis, transmission electron micrographs (TEM) for morphological analysis, and UV-Vis spectra for optical analysis. X-ray diffractograms exhibit mixed structures analysis (wurtzite and cubic) for particles obtained using 5-Bromo-4-hydroxy-3-methoxy-2-nitro benzaldehyde and 4NNbiscyno diethylamino benzaldehyde. However, the particles obtained by p-amino acetophenone Schiff bases of SBDTC exhibit only wurtzite structure. Variation in optical properties is also observed with the precursors used. The excellent optical properties of ZnS nanoparticles signify the role of microwave irradiation in synthesis. The Photoluminescence (PL) study shows the luminescence in the visible region and the maximum intensity for ZnS particles obtained by zinc complex of p-amino acetophenone Schiff base of S-benzyl dithiocarbazate. The microwave-assisted process can be used for large-scale production of nanoparticles for emitting light in the visible region in various detecting and sensing applications.

Variability in growth and biosynthetic activity of Calendula officinalis hairy roots.

Calendula officinalis is a widespread medicinal plant with a sufficiently well-studied chemical composition. Secondary metabolites synthesized by C.officinalis plants have pharmacological value for treating numerous diseases, and various types of aseptic in vitro cultures can be used as a source of these compounds. From this perspective, hairy roots attract considerable attention for the production of bioactive chemicals, including flavonoids with antioxidant activity. This paper shows the possibility of C.officinalis hairy roots obtaining with 100% frequency by Agrobacterium rhizogenes genetic transformation. Hairy root lines differed in growth rate and flavonoid content. In particular, flavonoids were accumulated in the amount of up to 6.68 ± 0.28 mg/g of wet weight. Methyl jasmonate in the concentration of 10 µM inhibited root growth to a small extent but stimulated the synthesis of flavonoids. The antioxidant activity and the reducing power increased in the roots grown in the medium with methyl jasmonate. The strong correlation of antioxidant activity and reducing power with flavonoid content was detected. The influence of extraction conditions on the content of flavonoids in the extracts and their bioactivity was determined. The potent reducing activity of extracts from hairy roots allowed the production of silver nanoparticles, which was confirmed by transmission electron microscopy.

Silver nanoparticles synthesized using aerial part of Achillea fragrantissima and evaluation of their bioactivities

Achillea fragrantissima (A. fragrantissima), a desert plant, is used internally in Arabian traditional medicine to treat inflammatory, spasmodic gastrointestinal disorders, and hepatobiliary diseases. The study focuses on the environmentally friendly production of silver nanoparticles (AgNPs) from the water-based aerial parts of the A. fragrantissima plant and their ability to kill bacteria and cells. Ultraviolet-visible (UV-Vis) spectroscopy, scanning electron microscopy (SEM) with energy dispersive X-ray (EDX) analysis, transmission electron microscopy (TEM), and Fourier transform infrared spectroscopy (FTIR) were used to describe the AgNPs. They were then tested for their ability to fight cancer and bacteria. A change in colour from yellow to brown and a surface plasmon resonance peak at 440 nm, seen with UV-Vis spectroscopy, showed that AgNPs had formed. In a Gas Chromatography-Mass Spectrometry (GC-MS) test of the aerial parts of A. fragrantissima, twenty bioactive components were found. These included isolongifolol and 3E,10Z-Oxacyclotrideca-3,10-diene-2,7-dione, methylbuta-1,3-dienyl)-7-oxabicyclo [4.1.0] heptan-3-ol. The extract exhibited high phenolic and flavonoid content (77.52 ± 1.46 mg GAE/g dry weight and 59 ± 2.17 mg QE/g dry weight, respectively). According to the IC50 values of 17.2 ± 1.18 and 14 ± 2.43 µg/mL, the AgNPs had a lot of power to kill cancer cells from the MCF-7 and HepG2 lines. Some genes that cause cell death (caspase-3, 8, 9, and Bax) were turned on more in the treated cells compared to the control cells that had not been treated. These genes were Bcl-xL and Bcl-2. Additionally, substantial activity against both Gram-positive bacteria and Gram-negative bacteria was found by antibacterial screening. Overall, this study underscores A. fragrantissima’s diverse biological activity and its potential in drug discovery and nanomedicine, promoting the development of natural antibacterial and anticancer therapies.

RABV antigenic peptide loaded polymeric nanoparticle production, characterization, and preliminary investigation of its biological activity

Nanoparticle-based antigen carrier systems have become a significant area of research with the advancement of nanotechnology. Biodegradable polymers have emerged as particularly promising carrier vehicles due to their ability to address the limitations of existing vaccine systems. In this study, we successfully encapsulated the G5-24 linear peptide, located between amino acids 253 and 275 in the primary sequence of the rabies virus G protein, into biodegradable and biocompatible PLGA copolymer using the double emulsion solvent evaporation method. The resulting nanoparticles had a size of approximately 230.9 ± 0.9074 nm, with a PDI value of 0.168 ± 0.017 and a zeta potential value of -9.86 ± 0.132 mV. SEM images confirmed that the synthesized nanoparticles were uniform in size and distribution. Additionally, FTIR spectra indicated successful peptide loading into the nanoparticles. The encapsulation efficiency of the peptide-loaded nanoparticles was 73.3%, with a peptide loading capacity of 48.2% and a reaction yield of 30.4%. Peptide release studies demonstrated that 65.55% of the peptide was released in a controlled manner over 28 d, following a 'biphasic burst release' profile consistent with the degradation profile of PLGA. This controlled release is particularly beneficial for vaccine studies. Cytotoxicity tests revealed that the R-NP formulation did not induce cytotoxicity in fibroblast cells and enhanced NO production in macrophages, indicating its potential for vaccine development.

Insights into the enhancement of nanoparticle production throughput by atmospheric-pressure spark ablation

Insights into the enhancement of nanoparticle production throughput by atmospheric-pressure spark ablation

3D and 4D Technology for Pharmaceutical Drug Delivery: A Detailed Insight

3D Printing, sometimes referred to as additive manufacturing, has made the concept of personalized medicine a reality. The primary objective of 3D and 4D printing is to produce intricate, customized pharmaceuticals at a reasonable cost. With improvements in materials, resolution, and speed, 3D printing technology is quickly developing. It includes faster construction, cost efficiency through reduced waste, design flexibility for complex structures, and sustainability through optimized material usage. An extensive literature survey was done on 3D and 4D printing of pharmaceuticals using PubMed, Elsevier, ScienceDirect, and Springer. The results were then filtered based on the titles, abstracts, and accessibility of the complete texts. The search engine Google Scholar was accessed for literature data mining. From the data mining, it was found that from the year 2009 to 2024 the number of research publications surged more than 200 times on the current topic. Even though 3-D and 4-D printing technologies have advanced significantly in a short amount of time, the most often used ones are still stereolithography, nozzle-based deposition, inkjet, and selective laser sintering. Their use has been modified for the production of nanoparticles, polypills, tablets, and implants, etc. Pharma's aspirations for tailored medications are being revolutionized by 3D printing, but cost, flexibility, and bioequivalence still need to be investigated. The present review offers a thorough analysis of various 3D and 4D printing methods and emphasizes the major advantages and disadvantages and major key challenges of 3D and 4D printing related to pharmaceuticals. Compared to 3D Printing, 4D printing offers better quality, efficacy, and functionality.

Diffusive micromixing combined with dynamic in situ laser scattering allows shedding light on lipid nanoparticle precipitation

Pharmaceutical formulations are increasingly based on drug nanoparticles or carrier nanoparticles encapsulating drugs or mRNA molecules. Sizes and monodispersity of the nanoparticles regulate bioavailability, pharmacokinetics and pharmacology. Microfluidic mixers promise unique conditions for their continuous preparation. A novel microfluidic antisolvent precipitation device was realized by two-photon-polymerization with a mixing channel in which the organic phase formed a sheet with a homogeneous thickness of down to 7 μm completely wrapped in the aqueous phase. Homogeneous diffusion through the sheet accelerates mixing. Optical access was implemented to allow in-situ dynamic light scattering. By centering the thin sheet in the microchannel cross-section, two important requirements are met. On the one hand, the organic phase never reaches the channel walls, avoiding fouling and unstable flow conditions. On the other hand, in the sheet positioned at the maximum of the parabolic flow profile the nanoparticle velocities are homogenized which enables flow-compensated Dynamic Light Scattering (flowDLS). These unique features allowed in-situ particle size determination for the first time. Monitoring of lipid nanoparticle precipitation was demonstrated for different rates of solvent and antisolvent flows. This breakthrough innovation will not only enable feedback control of nanoparticle production but also will provide new insights into the dynamics of nanoparticle precipitation.

Copper Nanoparticles Green-Formulated byCurcuma longa Extract Induce Apoptosis via P53 and STAT3 Signaling Pathways in Bladder Carcinoma Cell.

The study outlines the production of new copper nanoparticles infused with Curcuma longa extract to trigger apoptosis through P53 and signal transducer and activator of transcription 3 (STAT3) signaling pathways in bladder carcinoma cells. The structural characteristics of the nanoparticles that were synthesized were analyzed through various sophisticated methods such as transmission electron microscopy (TEM), field emission-scanning electron microscopy (FE-SEM), energy dispersive X-ray spectroscopy (EDX), and Fourier transform infrared spectroscopy (FT-IR). During the antioxidant evaluation, the IC50 values for copper nanoparticles and butylated hydroxytoluene (BHT) against 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radicals were found to be 116µg/mL and 31µg/mL, respectively. The cells treated with copper nanoparticles underwent evaluation through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay for 48h to determine their anticancer properties on TCCSUP bladder carcinoma cell. The TCCSUP cell line exhibited an IC50 of 290µg/mL when exposed to copper nanoparticles. The viability of malignant cells decreased upon treatment with copper nanoparticles. Furthermore, the copper nanoparticles presence led to a 65-75% increase in cell apoptosis, along with an increase in Bax and cleaved caspase-8 and a decrease in the Bcl-2. Furthermore, the copper nanoparticles presence resulted in the suppression of colony formation. Notably, the molecular pathway analysis in cells treated with copper NPs demonstrated an increase in p53 expression, along with a decrease in the expression of both total and phosphorylated STAT3. This offers that p53 and STAT3 play a crucial role in the biological efficacies induced by the nanoparticles in human carcinoma cells. The data of our research suggest that copper NPs could have significant potential as an anticancer treatment for human bladder carcinoma cells.

Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles.

The COVID-19 pandemic has raised concern regarding respiratory system diseases and oral inhalation stands out as an attractive non-invasive route of administration for pulmonary diseases such as chronic bronchitis, cystic fibrosis, COVID-19 and community-acquired pneumonia. In this context, we encapsulated azithromycin in polycaprolactone nanoparticles functionalized with phospholipids rich in dipalmitoylphosphatidylcholine and further produced a fine powder formulation by spray drying with monohydrated lactose. Nanoparticles obtained by the emulsion/solvent diffusion-evaporation technique exhibited a mean hydrodynamic diameter around 195-228nm with a narrow monomodal size distribution (PdI < 0.2). Nanoparticle dispersions were spray-dried at different inlet temperatures, atomizing air-flow, aspirator air flow, and feed rate, using lactose as a drying aid, resulting in a maximal process yield of 63% and an encapsulation efficiency of 83%. Excipients and the dry powder formulations were characterized in terms of morphology, chemical structure, thermal analyses and particle size by SEM, FTIR, DSC/TGA and laser light diffraction. The results indicated spherical particles with 90% at 4.06µm or below, an adequate size for pulmonary delivery. Aerosolization performance in a NGI confirmed good aerodynamic properties. Microbiological assays showed that the formulation preserves AZM antimicrobial effect against Staphylococcus aureus and Streptococcus pneumoniae strains, with halos above 18mm. In addition, no formulation-related cytotoxicity was observed against the human cell lines BEAS-2B (lung epithelial), HUVEC (endothelial) and HFF1 (fibroblasts). Overall, the approach described here allows the production of AZM-PCL nanoparticles incorporated into inhalable microparticles, enabling more efficient pulmonary therapy of lung infections.